Yanni Souroutzidis

Stock Analyst at Cantor Fitzgerald

(1.77)
# 3,358
Out of 5,241 analysts
1
Total ratings
50%
Success rate
8.21%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Yanni Souroutzidis

Karyopharm Therapeutics
Feb 5, 2026
Initiates: Overweight
Price Target: n/a
Current: $7.14
Upside: -